Vespa crabro chromosome 21, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342420.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
alkaline phosphatase 4-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
alkaline phosphatase 4-like, transcript variant X2
mitochondrial RNA pseudouridine synthase Rpusd4-like
ionotropic receptor 25a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ionotropic receptor 25a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ionotropic receptor 25a, transcript variant X4
ionotropic receptor 25a, transcript variant X3
ionotropic receptor 25a, transcript variant X5
ionotropic receptor 25a, transcript variant X2
ionotropic receptor 25a, transcript variant X1
tyramine receptor 1, transcript variant X1
tyramine receptor 1, transcript variant X4
tyramine receptor 1, transcript variant X3
tyramine receptor 1, transcript variant X2
delta-1-pyrroline-5-carboxylate synthase, transcript variant X3
delta-1-pyrroline-5-carboxylate synthase, transcript variant X2
delta-1-pyrroline-5-carboxylate synthase, transcript variant X1
delta-1-pyrroline-5-carboxylate synthase isoform X1
delta-1-pyrroline-5-carboxylate synthase, transcript variant X4
delta-1-pyrroline-5-carboxylate synthase isoform X2
U4/U6 small nuclear ribonucleoprotein Prp4, transcript variant X1
U4/U6 small nuclear ribonucleoprotein Prp4, transcript variant X2
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X2
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X1
cysteine-rich hydrophobic domain-containing protein 2, transcript variant X2
cysteine-rich hydrophobic domain-containing protein 2, transcript variant X1
cysteine-rich hydrophobic domain-containing protein 2
SH3 domain-containing protein 19, transcript variant X2
SH3 domain-containing protein 19, transcript variant X4
SH3 domain-containing protein 19, transcript variant X3
SH3 domain-containing protein 19, transcript variant X1
SH3 domain-containing protein 19 isoform X2
SH3 domain-containing protein 19 isoform X1
SH3 domain-containing protein 19 isoform X3
tribbles homolog 2, transcript variant X2
tribbles homolog 2, transcript variant X1
probable RNA methyltransferase CG11342, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable RNA methyltransferase CG11342, transcript variant X1
chromatin complexes subunit BAP18, transcript variant X2
chromatin complexes subunit BAP18 isoform X2
chromatin complexes subunit BAP18, transcript variant X1
chromatin complexes subunit BAP18, transcript variant X3
chromatin complexes subunit BAP18 isoform X1
chromatin complexes subunit BAP18 isoform X3
major facilitator superfamily domain-containing protein 1-like, transcript variant X1
major facilitator superfamily domain-containing protein 1-like, transcript variant X2
major facilitator superfamily domain-containing protein 1-like isoform X1
major facilitator superfamily domain-containing protein 1-like isoform X2
ATP-dependent RNA helicase DHX33-like, transcript variant X1
ATP-dependent RNA helicase DHX33-like, transcript variant X2
neuroligin-1-like, transcript variant X3
neuroligin-1-like, transcript variant X4
neuroligin-1-like, transcript variant X1
neuroligin-1-like, transcript variant X2
neuroligin-1-like, transcript variant X5
uncharacterized protein LOC124431311 isoform X1
uncharacterized protein LOC124431311 isoform X2
uncharacterized LOC124431318, transcript variant X2
uncharacterized LOC124431318, transcript variant X1
uncharacterized LOC124431318, transcript variant X3
uncharacterized LOC124431318, transcript variant X4
growth hormone-inducible transmembrane protein-like, transcript variant X1
growth hormone-inducible transmembrane protein-like, transcript variant X2
growth hormone-inducible transmembrane protein-like
schwannomin-interacting protein 1 homolog, transcript variant X1
schwannomin-interacting protein 1 homolog, transcript variant X5
schwannomin-interacting protein 1 homolog isoform X3
schwannomin-interacting protein 1 homolog, transcript variant X2
schwannomin-interacting protein 1 homolog, transcript variant X3
schwannomin-interacting protein 1 homolog, transcript variant X4
rho-associated protein kinase 2, transcript variant X3
rho-associated protein kinase 2, transcript variant X2
rho-associated protein kinase 2, transcript variant X1
rho-associated protein kinase 2, transcript variant X5
rho-associated protein kinase 2, transcript variant X4
rho-associated protein kinase 2 isoform X3
rho-associated protein kinase 2 isoform X2
rho-associated protein kinase 2 isoform X1
protein O-mannosyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein O-mannosyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein O-mannosyltransferase 1 isoform X1
protein O-mannosyltransferase 1 isoform X2
ATPase WRNIP1-like, transcript variant X3
ATPase WRNIP1-like, transcript variant X1
ATPase WRNIP1-like, transcript variant X2
methyltransferase-like 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
methyltransferase-like 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
WD repeat-containing protein 7, transcript variant X1
WD repeat-containing protein 7, transcript variant X3
WD repeat-containing protein 7, transcript variant X8
WD repeat-containing protein 7, transcript variant X9
WD repeat-containing protein 7, transcript variant X2
WD repeat-containing protein 7, transcript variant X5
WD repeat-containing protein 7, transcript variant X6
WD repeat-containing protein 7, transcript variant X4
WD repeat-containing protein 7, transcript variant X7
WD repeat-containing protein 7 isoform X1
WD repeat-containing protein 7 isoform X3
WD repeat-containing protein 7 isoform X8
WD repeat-containing protein 7 isoform X9
WD repeat-containing protein 7 isoform X2
WD repeat-containing protein 7 isoform X5
WD repeat-containing protein 7 isoform X6
WD repeat-containing protein 7 isoform X4
WD repeat-containing protein 7 isoform X7
probable nuclear hormone receptor HR3, transcript variant X7
probable nuclear hormone receptor HR3, transcript variant X8
probable nuclear hormone receptor HR3, transcript variant X5
probable nuclear hormone receptor HR3, transcript variant X10
probable nuclear hormone receptor HR3, transcript variant X6
probable nuclear hormone receptor HR3, transcript variant X11
probable nuclear hormone receptor HR3, transcript variant X1
probable nuclear hormone receptor HR3, transcript variant X3
probable nuclear hormone receptor HR3, transcript variant X2
probable nuclear hormone receptor HR3, transcript variant X4
probable nuclear hormone receptor HR3, transcript variant X9
probable nuclear hormone receptor HR3 isoform X5
probable nuclear hormone receptor HR3 isoform X6
probable nuclear hormone receptor HR3 isoform X8
probable nuclear hormone receptor HR3 isoform X3
probable nuclear hormone receptor HR3 isoform X9
probable nuclear hormone receptor HR3 isoform X4
probable nuclear hormone receptor HR3 isoform X7
probable nuclear hormone receptor HR3 isoform X2
probable nuclear hormone receptor HR3 isoform X1
histidine decarboxylase, transcript variant X3
histidine decarboxylase, transcript variant X1
histidine decarboxylase, transcript variant X2
coiled-coil domain-containing protein 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124431354, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124431354, transcript variant X2
uncharacterized LOC124431354, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124431354, transcript variant X4
uncharacterized LOC124431354, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X1
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X3
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X5
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X2
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X4
phosphoinositide 3-kinase regulatory subunit 4 isoform X1
phosphoinositide 3-kinase regulatory subunit 4 isoform X2
phosphoinositide 3-kinase regulatory subunit 4 isoform X4
phosphoinositide 3-kinase regulatory subunit 4 isoform X3
vesicle transport protein SEC20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
vesicle transport protein SEC20, transcript variant X3
vesicle transport protein SEC20, transcript variant X2
vesicle transport protein SEC20, transcript variant X1
isocitrate dehydrogenase [NAD] subunit beta, mitochondrial
methenyltetrahydrofolate synthase domain-containing protein
serine/threonine-protein kinase 32A, transcript variant X8
serine/threonine-protein kinase 32A, transcript variant X7
serine/threonine-protein kinase 32A, transcript variant X4
serine/threonine-protein kinase 32A, transcript variant X1
serine/threonine-protein kinase 32A, transcript variant X3
serine/threonine-protein kinase 32A, transcript variant X2
serine/threonine-protein kinase 32A, transcript variant X5
serine/threonine-protein kinase 32A, transcript variant X6
serine/threonine-protein kinase 32A, transcript variant X9
serine/threonine-protein kinase 32B isoform X4
serine/threonine-protein kinase 32A isoform X2
serine/threonine-protein kinase 32A isoform X1
serine/threonine-protein kinase 32A isoform X3
serine/threonine-protein kinase 32A isoform X5
serine/threonine-protein kinase 32B isoform X6
protein Star-like, transcript variant X2
protein Star-like, transcript variant X3
protein Star-like, transcript variant X1
protein Star-like, transcript variant X4
facilitated trehalose transporter Tret1-like
26S proteasome non-ATPase regulatory subunit 2-like
actin-binding LIM protein 2, transcript variant X10
actin-binding LIM protein 2, transcript variant X22
actin-binding LIM protein 2, transcript variant X11
actin-binding LIM protein 2, transcript variant X7
actin-binding LIM protein 2, transcript variant X14
actin-binding LIM protein 2, transcript variant X13
actin-binding LIM protein 2, transcript variant X9
actin-binding LIM protein 2, transcript variant X4
actin-binding LIM protein 2, transcript variant X6
actin-binding LIM protein 2, transcript variant X2
actin-binding LIM protein 2, transcript variant X12
actin-binding LIM protein 2, transcript variant X8
actin-binding LIM protein 2, transcript variant X3
actin-binding LIM protein 2, transcript variant X5
actin-binding LIM protein 2, transcript variant X1
actin-binding LIM protein 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X15
actin-binding LIM protein 2, transcript variant X21
LIM domain only protein 3-like, transcript variant X3
LIM domain only protein 3-like, transcript variant X1
uncharacterized protein LOC124431386 isoform X1
LIM domain only protein 3-like isoform X2
LIM domain only protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 3
CCR4-NOT transcription complex subunit 11
dynein heavy chain, cytoplasmic, transcript variant X2
dynein heavy chain, cytoplasmic, transcript variant X1
dynein heavy chain, cytoplasmic, transcript variant X3
dynein heavy chain, cytoplasmic, transcript variant X4
dynein heavy chain, cytoplasmic, transcript variant X5
dynein heavy chain, cytoplasmic isoform X2
dynein heavy chain, cytoplasmic isoform X1
dynein heavy chain, cytoplasmic isoform X3
dynein heavy chain, cytoplasmic isoform X4
dynein heavy chain, cytoplasmic isoform X5
sodium-dependent transporter bedraggled, transcript variant X3
sodium-dependent transporter bedraggled, transcript variant X1
sodium-dependent transporter bedraggled, transcript variant X2
sodium-dependent transporter bedraggled isoform X2
sodium-dependent transporter bedraggled isoform X1
acetyl-CoA acetyltransferase, mitochondrial, transcript variant X1
acetyl-CoA acetyltransferase, mitochondrial isoform X1
acetyl-CoA acetyltransferase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
acetyl-CoA acetyltransferase, mitochondrial isoform X2
baculoviral IAP repeat-containing protein 7-like, transcript variant X2
baculoviral IAP repeat-containing protein 7-like, transcript variant X1
baculoviral IAP repeat-containing protein 7-like isoform X1
baculoviral IAP repeat-containing protein 7-like isoform X2
baculoviral IAP repeat-containing protein 7-B-like, transcript variant X1
baculoviral IAP repeat-containing protein 7-B-like, transcript variant X2
baculoviral IAP repeat-containing protein 7-B-like
dual specificity protein phosphatase CDC14A-like, transcript variant X7
dual specificity protein phosphatase CDC14A-like, transcript variant X4
dual specificity protein phosphatase CDC14A-like, transcript variant X2
dual specificity protein phosphatase CDC14A-like, transcript variant X1
dual specificity protein phosphatase CDC14A-like, transcript variant X6
dual specificity protein phosphatase CDC14A-like, transcript variant X5
dual specificity protein phosphatase CDC14A-like, transcript variant X3
dual specificity protein phosphatase CDC14C-like isoform X1
dual specificity protein phosphatase CDC14A-like isoform X4
dual specificity protein phosphatase CDC14C-like isoform X2
dual specificity protein phosphatase CDC14C-like isoform X3
cell division cycle protein 20 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle protein 20 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cell division cycle protein 20 homolog isoform X1
cell division cycle protein 20 homolog isoform X2
F-box only protein 44-like, transcript variant X2
F-box only protein 44-like, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
zinc finger protein 521, transcript variant X1
zinc finger protein 521, transcript variant X2
solute carrier family 41 member 3-like, transcript variant X3
solute carrier family 41 member 3-like, transcript variant X2
solute carrier family 41 member 3-like, transcript variant X1
solute carrier family 41 member 3-like isoform X1
solute carrier family 41 member 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 4-like, transcript variant X1
FYVE, RhoGEF and PH domain-containing protein 4-like, transcript variant X3
FYVE, RhoGEF and PH domain-containing protein 4-like, transcript variant X2
FYVE, RhoGEF and PH domain-containing protein 4-like
cytochrome P450 6k1-like, transcript variant X5
cytochrome P450 6k1-like, transcript variant X2
cytochrome P450 6k1-like, transcript variant X4
cytochrome P450 6k1-like, transcript variant X3
cytochrome P450 6k1-like, transcript variant X1
solute carrier family 41 member 1-like, transcript variant X3
solute carrier family 41 member 1-like, transcript variant X4
solute carrier family 41 member 1-like, transcript variant X5
solute carrier family 41 member 1-like, transcript variant X1
solute carrier family 41 member 1-like, transcript variant X2
solute carrier family 41 member 1-like isoform X2
solute carrier family 41 member 1-like isoform X1
solute carrier family 41 member 1-like isoform X3
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like isoform X2
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like, transcript variant X4
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X5
facilitated trehalose transporter Tret1-like isoform X3
uncharacterized LOC124431302, transcript variant X1
uncharacterized LOC124431302, transcript variant X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
uncharacterized LOC124431381, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124431381, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nucleoporin p58/p45-like, transcript variant X1
nucleoporin p58/p45-like, transcript variant X6
nucleoporin p58/p45-like, transcript variant X4
nucleoporin p58/p45-like, transcript variant X8
nucleoporin p58/p45-like, transcript variant X7
nucleoporin p58/p45-like, transcript variant X5
nucleoporin p58/p45-like, transcript variant X3
nucleoporin p58/p45-like, transcript variant X2
RNA-binding protein 25, transcript variant X8
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124431487, transcript variant X2
uncharacterized LOC124431487, transcript variant X1
serine/threonine-protein kinase VRK1-like, transcript variant X1
serine/threonine-protein kinase VRK1-like, transcript variant X2
serine/threonine-protein kinase VRK1-like
RNA-binding protein 25, transcript variant X5
RNA-binding protein 25, transcript variant X6
RNA-binding protein 25, transcript variant X1
RNA-binding protein 25, transcript variant X3
RNA-binding protein 25, transcript variant X2
RNA-binding protein 25, transcript variant X4
RNA-binding protein 25, transcript variant X10
RNA-binding protein 25, transcript variant X7
RNA-binding protein 25, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C2 domain-containing protein 3-like, transcript variant X1
C2 domain-containing protein 3-like, transcript variant X2
uncharacterized protein LOC124431323 isoform X1
C2 domain-containing protein 3-like isoform X2
C2 domain-containing protein 3-like, transcript variant X3
uncharacterized protein LOC124431323 isoform X3
general transcription factor IIH subunit 1, transcript variant X1
general transcription factor IIH subunit 1, transcript variant X2
general transcription factor IIH subunit 1, transcript variant X3
general transcription factor IIH subunit 1
POC1 centriolar protein homolog A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
POC1 centriolar protein homolog A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SH2B adapter protein 1-like, transcript variant X2
SH2B adapter protein 1-like, transcript variant X1
SH2B adapter protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
putative tricarboxylate transport protein, mitochondrial
tetratricopeptide repeat protein 28, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tetratricopeptide repeat protein 28, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tetratricopeptide repeat protein 28, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
peptidyl-tRNA hydrolase 2, mitochondrial-like, transcript variant X3
peptidyl-tRNA hydrolase 2, mitochondrial-like, transcript variant X2
peptidyl-tRNA hydrolase 2, mitochondrial-like, transcript variant X1
peptidyl-tRNA hydrolase 2, mitochondrial-like
gamma-interferon-inducible lysosomal thiol reductase-like
DNA-directed RNA polymerases I and III subunit RPAC1
guanine nucleotide-binding protein subunit gamma-1, transcript variant X2
guanine nucleotide-binding protein subunit gamma-1, transcript variant X1
guanine nucleotide-binding protein subunit gamma-1
RNA polymerase-associated protein RTF1 homolog
cofilin/actin-depolymerizing factor homolog, transcript variant X4
cofilin/actin-depolymerizing factor homolog isoform X4
cofilin/actin-depolymerizing factor homolog, transcript variant X3
cofilin/actin-depolymerizing factor homolog isoform X3
cofilin/actin-depolymerizing factor homolog, transcript variant X1
cofilin/actin-depolymerizing factor homolog isoform X1
cofilin/actin-depolymerizing factor homolog, transcript variant X2
cofilin/actin-depolymerizing factor homolog isoform X2
limbic system-associated membrane protein-like
uncharacterized LOC124431438, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124431438, transcript variant X2
uncharacterized protein LOC124431438 isoform X1
uncharacterized protein LOC124431438 isoform X2
uncharacterized LOC124431440, transcript variant X3
uncharacterized protein LOC124431440 isoform X2
uncharacterized LOC124431440, transcript variant X1
uncharacterized LOC124431440, transcript variant X2
uncharacterized protein LOC124431440 isoform X1
centromere-associated protein E-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
centromere-associated protein E-like, transcript variant X1
centromere-associated protein E-like isoform X2
golgin subfamily A member 4-like isoform X1
signal recognition particle 9 kDa protein, transcript variant X2
signal recognition particle 9 kDa protein, transcript variant X1
signal recognition particle 9 kDa protein
band 4.1-like protein 4, transcript variant X3
band 4.1-like protein 4, transcript variant X2
band 4.1-like protein 4, transcript variant X1
thyroid receptor-interacting protein 11, transcript variant X1
thyroid receptor-interacting protein 11, transcript variant X3
thyroid receptor-interacting protein 11 isoform X1
thyroid receptor-interacting protein 11 isoform X3
thyroid receptor-interacting protein 11, transcript variant X4
thyroid receptor-interacting protein 11, transcript variant X2
thyroid receptor-interacting protein 11 isoform X2
thyroid receptor-interacting protein 11 isoform X4
homeodomain-interacting protein kinase 2, transcript variant X13
homeodomain-interacting protein kinase 2, transcript variant X11
homeodomain-interacting protein kinase 2, transcript variant X12
homeodomain-interacting protein kinase 2, transcript variant X9
homeodomain-interacting protein kinase 2, transcript variant X10
homeodomain-interacting protein kinase 2, transcript variant X3
homeodomain-interacting protein kinase 2, transcript variant X5
homeodomain-interacting protein kinase 2, transcript variant X15
homeodomain-interacting protein kinase 2, transcript variant X8
homeodomain-interacting protein kinase 2, transcript variant X16
homeodomain-interacting protein kinase 2, transcript variant X2
homeodomain-interacting protein kinase 2, transcript variant X14
homeodomain-interacting protein kinase 2, transcript variant X7
homeodomain-interacting protein kinase 2, transcript variant X6
homeodomain-interacting protein kinase 2, transcript variant X1
homeodomain-interacting protein kinase 2, transcript variant X4
homeodomain-interacting protein kinase 2 isoform X2
homeodomain-interacting protein kinase 2 isoform X5
homeodomain-interacting protein kinase 2 isoform X4
homeodomain-interacting protein kinase 2 isoform X11
homeodomain-interacting protein kinase 2 isoform X3
homeodomain-interacting protein kinase 2 isoform X8
homeodomain-interacting protein kinase 2 isoform X12
homeodomain-interacting protein kinase 2 isoform X10
homeodomain-interacting protein kinase 2 isoform X7
homeodomain-interacting protein kinase 2 isoform X6
homeodomain-interacting protein kinase 2 isoform X1
homeodomain-interacting protein kinase 2 isoform X9
lysosome-associated membrane glycoprotein 2-like
uncharacterized LOC124431422, transcript variant X9
uncharacterized LOC124431422, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124431422, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124431422, transcript variant X2
uncharacterized LOC124431422, transcript variant X5
uncharacterized LOC124431422, transcript variant X8
uncharacterized LOC124431422, transcript variant X7
uncharacterized LOC124431422, transcript variant X3
uncharacterized LOC124431422, transcript variant X1
UPF0329 protein ECU05_1680/ECU11_0050-like, transcript variant X2
UPF0329 protein ECU05_1680/ECU11_0050-like isoform X2
UPF0329 protein ECU05_1680/ECU11_0050-like, transcript variant X4
UPF0329 protein ECU05_1680/ECU11_0050-like, transcript variant X3
UPF0329 protein ECU05_1680/ECU11_0050-like, transcript variant X5
UPF0329 protein ECU05_1680/ECU11_0050-like, transcript variant X1
UPF0329 protein ECU05_1680/ECU11_0050-like isoform X1
UPF0329 protein ECU05_1680/ECU11_0050-like isoform X3
cell wall protein DAN4-like, transcript variant X1
cell wall protein DAN4-like, transcript variant X2
uncharacterized LOC124431425, transcript variant X2
uncharacterized LOC124431425, transcript variant X1
uncharacterized LOC124431425, transcript variant X3
uncharacterized LOC124431423, transcript variant X1
uncharacterized LOC124431423, transcript variant X4
uncharacterized LOC124431423, transcript variant X2
uncharacterized LOC124431423, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
CWF19-like protein 2, transcript variant X3
CWF19-like protein 2, transcript variant X1
CWF19-like protein 2, transcript variant X2
protein arginine methyltransferase NDUFAF7, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X8
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X10
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X9
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X11
mitogen-activated protein kinase kinase kinase kinase 5 isoform X1
mitogen-activated protein kinase kinase kinase kinase 5 isoform X3
mitogen-activated protein kinase kinase kinase kinase 5 isoform X5
mitogen-activated protein kinase kinase kinase kinase 5 isoform X7
mitogen-activated protein kinase kinase kinase kinase 5 isoform X2
mitogen-activated protein kinase kinase kinase kinase 5 isoform X6
mitogen-activated protein kinase kinase kinase kinase 5 isoform X9
mitogen-activated protein kinase kinase kinase kinase 5 isoform X8
mitogen-activated protein kinase kinase kinase kinase 3 isoform X10
mitogen-activated protein kinase kinase kinase kinase 5 isoform X4
putative uncharacterized protein DDB_G0282133, transcript variant X6
putative uncharacterized protein DDB_G0282133, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X3
putative uncharacterized protein DDB_G0282133, transcript variant X5
putative uncharacterized protein DDB_G0282133, transcript variant X4
putative uncharacterized protein DDB_G0282133, transcript variant X8
putative uncharacterized protein DDB_G0282133, transcript variant X1
putative uncharacterized protein DDB_G0282133, transcript variant X7
putative uncharacterized protein DDB_G0282133 isoform X2
putative uncharacterized protein DDB_G0282133 isoform X4
putative uncharacterized protein DDB_G0282133 isoform X1
putative uncharacterized protein DDB_G0282133 isoform X3
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
odorant receptor 13a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 13a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
brain tumor protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
brain tumor protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
brain tumor protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
serine-rich adhesin for platelets-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine-rich adhesin for platelets-like, transcript variant X1
serine-rich adhesin for platelets-like isoform X2
serine-rich adhesin for platelets-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
putative uncharacterized protein DDB_G0277255
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124431564, transcript variant X2
uncharacterized LOC124431564, transcript variant X8
uncharacterized LOC124431564, transcript variant X6
uncharacterized LOC124431564, transcript variant X9
uncharacterized LOC124431564, transcript variant X4
uncharacterized LOC124431564, transcript variant X3
uncharacterized LOC124431564, transcript variant X1
uncharacterized LOC124431564, transcript variant X5
uncharacterized LOC124431564, transcript variant X7
inositol oxygenase, transcript variant X2
inositol oxygenase, transcript variant X1
splicing factor, suppressor of white-apricot homolog, transcript variant X2
splicing factor, suppressor of white-apricot homolog, transcript variant X3
splicing factor, suppressor of white-apricot homolog, transcript variant X1
splicing factor, suppressor of white-apricot homolog, transcript variant X4
splicing factor, suppressor of white-apricot homolog, transcript variant X6
splicing factor, suppressor of white-apricot homolog, transcript variant X5
splicing factor, suppressor of white-apricot homolog isoform X2
splicing factor, suppressor of white-apricot homolog isoform X3
splicing factor, suppressor of white-apricot homolog isoform X1
splicing factor, suppressor of white-apricot homolog isoform X4
histone-lysine N-methyltransferase E(z), transcript variant X1
histone-lysine N-methyltransferase E(z), transcript variant X2
histone-lysine N-methyltransferase E(z), transcript variant X3
histone-lysine N-methyltransferase E(z), transcript variant X4
histone-lysine N-methyltransferase E(z) isoform X1
histone-lysine N-methyltransferase E(z) isoform X2
histone-lysine N-methyltransferase E(z) isoform X3
histone-lysine N-methyltransferase E(z) isoform X4
chitooligosaccharidolytic beta-N-acetylglucosaminidase
mediator of RNA polymerase II transcription subunit 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124431394, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124431394, transcript variant X1
autophagy-related protein 101, transcript variant X1
autophagy-related protein 101, transcript variant X2
prolactin-releasing peptide receptor-like, transcript variant X4
prolactin-releasing peptide receptor-like, transcript variant X3
prolactin-releasing peptide receptor-like, transcript variant X1
prolactin-releasing peptide receptor-like, transcript variant X8
prolactin-releasing peptide receptor-like, transcript variant X5
prolactin-releasing peptide receptor-like, transcript variant X7
prolactin-releasing peptide receptor-like, transcript variant X2
prolactin-releasing peptide receptor-like, transcript variant X6
prolactin-releasing peptide receptor-like
HMG box transcription factor BBX, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
HMG box transcription factor BBX isoform X2
HMG box transcription factor BBX, transcript variant X4
HMG box transcription factor BBX isoform X4
HMG box transcription factor BBX, transcript variant X5
HMG box transcription factor BBX isoform X5
HMG box transcription factor BBX, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
HMG box transcription factor BBX, transcript variant X1
HMG box transcription factor BBX isoform X1
uncharacterized protein DDB_G0288805 isoform X3
protein yippee-like 5, transcript variant X2
protein yippee-like 5, transcript variant X1
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X3
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X2
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X1
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X3
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X2
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X1
amyloid-beta-like protein, transcript variant X3
amyloid-beta-like protein, transcript variant X4
amyloid-beta-like protein, transcript variant X5
amyloid-beta-like protein, transcript variant X1
amyloid-beta-like protein, transcript variant X2
persulfide dioxygenase ETHE1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
E3 ubiquitin-protein ligase Su(dx), transcript variant X2
E3 ubiquitin-protein ligase Su(dx), transcript variant X1
E3 ubiquitin-protein ligase Su(dx), transcript variant X5
E3 ubiquitin-protein ligase Su(dx), transcript variant X4
E3 ubiquitin-protein ligase Su(dx), transcript variant X3
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X1
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X4
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X2
serine/threonine-protein phosphatase 1 regulatory subunit 10, transcript variant X3
serine/threonine-protein phosphatase 1 regulatory subunit 10
ranBP2-like and GRIP domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: odorant receptor Or1-like
dihydropyrimidine dehydrogenase [NADP(+)]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
differentially expressed in FDCP 8 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
differentially expressed in FDCP 8 homolog, transcript variant X1
differentially expressed in FDCP 8 homolog, transcript variant X3
differentially expressed in FDCP 8 homolog isoform X2
differentially expressed in FDCP 8 homolog isoform X1
28S ribosomal protein S18b, mitochondrial
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1
kinesin-like protein KIF14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin-like protein KIF14, transcript variant X1
trafficking protein particle complex subunit 3
lysM and putative peptidoglycan-binding domain-containing protein 2
protein catecholamines up, transcript variant X2
protein catecholamines up, transcript variant X3
protein catecholamines up, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane protein 268, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 268, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane protein 268, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC124431304 isoform X4
transmembrane protein 268, transcript variant X3
uncharacterized protein LOC124431304 isoform X3
tetratricopeptide repeat protein 19 homolog, mitochondrial, transcript variant X2
tetratricopeptide repeat protein 19 homolog, mitochondrial, transcript variant X1
tetratricopeptide repeat protein 19 homolog, mitochondrial
SAP30-binding protein, transcript variant X1
SAP30-binding protein, transcript variant X3
SAP30-binding protein, transcript variant X2
ADP-ribosylation factor-binding protein GGA3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein arginine N-methyltransferase 1, transcript variant X3
protein arginine N-methyltransferase 1, transcript variant X2
protein arginine N-methyltransferase 1, transcript variant X1
protein arginine N-methyltransferase 1 isoform X2
protein arginine N-methyltransferase 1 isoform X1
protein arginine N-methyltransferase 1 isoform X3
pyruvate dehydrogenase E1 component subunit beta, mitochondrial, transcript variant X2
pyruvate dehydrogenase E1 component subunit beta, mitochondrial, transcript variant X1
pyruvate dehydrogenase E1 component subunit beta, mitochondrial isoform X2
pyruvate dehydrogenase E1 component subunit beta, mitochondrial isoform X1
acidic fibroblast growth factor intracellular-binding protein, transcript variant X1
acidic fibroblast growth factor intracellular-binding protein
acidic fibroblast growth factor intracellular-binding protein, transcript variant X2
procathepsin L-like, transcript variant X3
procathepsin L-like, transcript variant X1
procathepsin L-like, transcript variant X2
microphthalmia-associated transcription factor, transcript variant X5
microphthalmia-associated transcription factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
microphthalmia-associated transcription factor, transcript variant X4
microphthalmia-associated transcription factor isoform X4
microphthalmia-associated transcription factor, transcript variant X3
microphthalmia-associated transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
microphthalmia-associated transcription factor, transcript variant X2
microphthalmia-associated transcription factor isoform X1
microphthalmia-associated transcription factor isoform X2
microphthalmia-associated transcription factor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC124431544, transcript variant X8
uncharacterized LOC124431544, transcript variant X3
uncharacterized LOC124431544, transcript variant X4
uncharacterized LOC124431544, transcript variant X1
uncharacterized LOC124431544, transcript variant X2
uncharacterized LOC124431544, transcript variant X7
uncharacterized LOC124431544, transcript variant X5
uncharacterized LOC124431544, transcript variant X6
uncharacterized protein LOC124431544 isoform X2
uncharacterized protein LOC124431544 isoform X1
ADAMTS-like protein 4, transcript variant X5
ADAMTS-like protein 4, transcript variant X6
ADAMTS-like protein 4, transcript variant X1
ADAMTS-like protein 4, transcript variant X2
ADAMTS-like protein 4, transcript variant X4
ADAMTS-like protein 4, transcript variant X3
ADAMTS-like protein 4, transcript variant X8
ADAMTS-like protein 4, transcript variant X7
ADAMTS-like protein 4, transcript variant X9
armadillo repeat-containing protein 6 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
armadillo repeat-containing protein 6 homolog, transcript variant X3
armadillo repeat-containing protein 6 homolog, transcript variant X2
armadillo repeat-containing protein 6 homolog, transcript variant X1
armadillo repeat-containing protein 6 homolog
GDP-fucose protein O-fucosyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sorting nexin-24-like, transcript variant X2
sorting nexin-24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
semaphorin-1A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
semaphorin-1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
alpha/beta hydrolase domain-containing protein 17B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
homer protein homolog 2, transcript variant X2
homer protein homolog 2, transcript variant X1
homer protein homolog 2, transcript variant X3
methylosome subunit pICln, transcript variant X2
methylosome subunit pICln, transcript variant X3
methylosome subunit pICln, transcript variant X1
GRIP and coiled-coil domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
GRIP and coiled-coil domain-containing protein 1, transcript variant X3
GRIP and coiled-coil domain-containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
GRIP and coiled-coil domain-containing protein 1
protein capicua homolog, transcript variant X2
protein capicua homolog, transcript variant X4
protein capicua homolog, transcript variant X3
protein capicua homolog, transcript variant X9
protein capicua homolog, transcript variant X7
protein capicua homolog, transcript variant X8
protein capicua homolog, transcript variant X10
protein capicua homolog, transcript variant X11
protein capicua homolog, transcript variant X6
protein capicua homolog, transcript variant X1
protein capicua homolog, transcript variant X5
putative transcription factor capicua isoform X5
putative transcription factor capicua isoform X2
putative transcription factor capicua isoform X6
putative transcription factor capicua isoform X1
histone-lysine N-methyltransferase trithorax
leukocyte tyrosine kinase receptor, transcript variant X6
leukocyte tyrosine kinase receptor, transcript variant X2
leukocyte tyrosine kinase receptor, transcript variant X1
leukocyte tyrosine kinase receptor, transcript variant X3
leukocyte tyrosine kinase receptor, transcript variant X4
leukocyte tyrosine kinase receptor, transcript variant X5
leukocyte tyrosine kinase receptor isoform X3
uncharacterized LOC124431453, transcript variant X4
uncharacterized LOC124431453, transcript variant X3
uncharacterized LOC124431453, transcript variant X1
uncharacterized LOC124431453, transcript variant X2
uncharacterized protein LOC124431453 isoform X1
uncharacterized protein LOC124431453 isoform X2
patched domain-containing protein 3-like
uncharacterized LOC124431478, transcript variant X1
uncharacterized LOC124431478, transcript variant X2
haloacid dehalogenase-like hydrolase domain-containing 5
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
telomerase reverse transcriptase-like, transcript variant X2
telomerase reverse transcriptase-like, transcript variant X1
telomerase reverse transcriptase-like, transcript variant X3
telomerase reverse transcriptase-like isoform X2
telomerase reverse transcriptase-like isoform X1
telomerase reverse transcriptase-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 17% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 4-like
uncharacterized LOC124431447, transcript variant X1
uncharacterized LOC124431447, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments